ArticleImmunotherapy advances2025

High level of anti-drug antibodies is associated with shorter survival in advanced solid cancer patients treated with Immune checkpoint inhibitors.

Rui Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.